Senator Urges FDA to Improve Orphan Drug Development

Drug Industry Daily
A A
To spur development of orphan drugs, the FDA should develop a system to prioritize the top 100 rare diseases, Sen. Sam Brownback (R-Kan.) said during a Senate subcommittee hearing.

To View This Article:

Login

Subscribe To Drug Industry Daily